van der Zijden, Charlène J.
van der Sluis, Pieter C.
Mostert, Bianca
Nuyttens, Joost J. M. E.
van Lanschot, J. Jan B.
Spaander, Manon C. W.
Valkema, Roelf
Coene, Peter Paul L. O.
Dekker, Jan Willem T.
Fiets, Willem E.
Hartgrink, Hendrik H.
Hazen, Wouter L.
Kouwenhoven, Ewout A.
Nieuwenhuijzen, Grard A. P.
Rosman, Camiel
van Sandick, Johanna W.
Sosef, Meindert N.
van der Zaag, Edwin S.
Lagarde, Sjoerd M.
Wijnhoven, Bas P. L.
Article History
Received: 8 February 2024
Accepted: 10 July 2024
First Online: 27 July 2024
Disclosure
: Bianca Mostert received research funding from Sanofi, Pfizer, and BMS and served as consulting/advisory for Lilly, Servier, BMS, Amgen and AstraZeneca. Ewout Kouwenhoven served as consulting/advisory for Intuitive Surgical. Grard Nieuwenhuijzen, Medtronic, and BMS. Bas Wijnhoven received research funding from BMS and served as consulting/advisory for BMS. The remaining authors have no conflicts of interest.